中文产业新闻评分59Chinese source
axatilimab 特发性肺纤维化二期试验未达主要终点
II期临床失败，股价大跌17%、市值蒸发近3亿美元
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
II期临床失败，股价大跌17%、市值蒸发近3亿美元
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.